{{Drugbox
| Watchedfields = changed
| verifiedrevid = 444611944
| IUPAC_name = (6,6,9-trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl)-4-(azepan-1-yl)butanoate
| image = Nabazenil_structure.png
| width = 200
| image2 = Nabazenil-3D-balls.png

<!--Clinical data-->
| tradename =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 58019-65-1
| PubChem = 163326
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = N1RX70K36C
| ChemSpiderID      = 143331

<!--Chemical data-->
| C=35 | H=55 | N=1 | O=3 
| molecular_weight = 537.814 g/mol
| smiles = CCCCCC(C)C(C)C1=CC2=C(C3=C(CCC(C3)C)C(O2)(C)C)C(=C1)OC(=O)CCCN4CCCCCC4
| StdInChI          = 1S/C35H55NO3/c1-7-8-11-15-26(3)27(4)28-23-31(38-33(37)16-14-21-36-19-12-9-10-13-20-36)34-29-22-25(2)17-18-30(29)35(5,6)39-32(34)24-28/h23-27H,7-22H2,1-6H3
| StdInChIKey       = DRVZFWZGQKGHQO-UHFFFAOYSA-N

}}

'''Nabazenil''' ('''SP-175''') is a synthetic [[cannabinoid receptor]] [[agonist]], which has [[anticonvulsant]] properties.<ref>Concise dictionary of pharmacological agents: properties and synonyms. p188. {{ISBN|0-7514-0499-3}}</ref>

== References ==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Cannabinoids]]
[[Category:Benzochromenes]]
[[Category:Azepanes]]
[[Category:Butyrates]]
[[category:anticonvulsants]]
{{Cannabinoid-stub}}